Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Patients with insulin-dep… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Patients with insulin-dependent diabetes but not those with non-insulin-dependent diabetes have anti-sulfatide antibodies as determined with a new ELISA assay

Artikel i vetenskaplig tidskrift
Författare Kerstin Andersson
K. Buschard
Pam Fredman
A. Kaas
Anna-Maria Lidström
S. Madsbad
H. Mortensen
Jan-Eric Månsson
Publicerad i Autoimmunity
Volym 35
Nummer/häfte 7
Sidor 463-8
ISSN 0891-6934
Publiceringsår 2002
Publicerad vid Institutionen för klinisk neurovetenskap, Sektionen för laborativ neurovetenskap
Sidor 463-8
Språk en
Länkar dx.doi.org/10.1080/0891693021000047...
Ämnesord Adolescent, Adult, Autoantibodies/blood/*immunology, Child, Child, Preschool, Diabetes Mellitus, Type 1/*immunology, Diabetes Mellitus, Type 2/*immunology, Enzyme-Linked Immunosorbent Assay, Female, Humans, Male, Middle Aged, Prediabetic State/immunology, Research Support, Non-U.S. Gov't, Sulfoglycosphingolipids/*immunology
Ämneskategorier Neurovetenskap

Sammanfattning

BACKGROUND: In sera from newly diagnosed insulin-dependent diabetes mellitus patients (IDDM type 1) autoantibodies occur against different antigen determinants often shared with neural tissues. The role of these autoantibodies in the disease process is not yet clarified but they can be used as a diagnostic tool in the detection of IDDM patients. METHODS: We have analysed the occurrence of sulfatide autoantibodies in serum from patients with type 1 diabetes (n = 20), individuals with pre-type 1 diabetes (n = 6), patients with type 2 diabetes (n = 32) and controls (n = 43). The method used for the determination of the autoantibodies was a newly developed microtitre-ELISA assay utilizing a complex of sulfatide-albumin as the ligand. RESULTS: The new assay procedure for serum sulfatide autoantibodies showed good reproducibility. The total (day-to-day) imprecision based on analyses of three different serum samples with positive titres varied between 11 and 14% during an assay period of 6 months. None of the controls (0/43) had positive titres of sulfatide antibodies. Of the patients with type 1 diabetes, 85% displayed positive titres of anti-sulfatide antibodies while none of the type 2 patients did so. All individuals with pre-type 1 diabetes had positive titres of sulfatide antibodies. CONCLUSIONS: We conclude that sulfatide autoantibodies in serum can be reproducibly assayed by the newly developed microtitre-ELISA procedure. Elevated titres of sulfatide autoantibodies are a constant finding in newly diagnosed type 1 patients.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?